NGOC TRAM DANG: Open Payments
NPI 1114534492 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,294 in 167 payments from 19 companies in 2025. Trend: 2023 $2,575 · 2024 $3,117 · 2025 $3,294
Food & beverage: $3,144Education: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $580 |
| Janssen Biotech, Inc. | 15 | $502 |
| Phathom Pharmaceuticals, Inc. | 17 | $320 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $282 |
| Ardelyx, Inc. | 13 | $235 |
| Gilead Sciences, Inc. | 6 | $222 |
| Intercept Pharmaceuticals, Inc. | 24 | $216 |
| Madrigal Pharmaceuticals | 11 | $200 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $194 |
| Celltrion USA Inc. | 4 | $92 |
Products named: TREMFYA, VOQUEZNA, ENTYVIO, IBSRELA, OCALIVA, REZDIFFRA, XIFAXAN, RINVOQ.
Industry payments across GA — which companies pay providers there.
